Institut Bergonié

🇫🇷France
Ownership
Private
Established
1923-01-01
Employees
-
Market Cap
-
Website
http://www.bergonie.org

Targeting ATR in Soft-tissue Sarcomas

First Posted Date
2021-03-19
Last Posted Date
2023-09-28
Lead Sponsor
Institut Bergonié
Target Recruit Count
72
Registration Number
NCT04807816
Locations
🇫🇷

Institut Gustave Roussy, Villejuif, France

🇫🇷

IUCT Oncopôle, Toulouse, France

🇫🇷

Centre Leon Berard, Lyon, France

and more 3 locations

Combining Epigenetic And Immune Therapy to Beat Cancer.

First Posted Date
2021-01-12
Last Posted Date
2023-03-01
Lead Sponsor
Institut Bergonié
Target Recruit Count
173
Registration Number
NCT04705818
Locations
🇫🇷

CHU Poitiers, Poitiers, France

🇫🇷

Institut Bergonie, Bordeaux, France

🇫🇷

CHRU Brest, Brest, France

Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2020-06-11
Last Posted Date
2024-01-12
Lead Sponsor
Institut Bergonié
Target Recruit Count
526
Registration Number
NCT04426006
Locations
🇫🇷

Institut Bergonié, Bordeaux, France

Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma

First Posted Date
2020-04-09
Last Posted Date
2024-11-19
Lead Sponsor
Institut Bergonié
Target Recruit Count
214
Registration Number
NCT04339218
Locations
🇫🇷

Institut Bergonié, Bordeaux, Gironde, France

Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study

Not Applicable
Recruiting
Conditions
Interventions
First Posted Date
2020-02-06
Last Posted Date
2023-03-02
Lead Sponsor
Institut Bergonié
Target Recruit Count
332
Registration Number
NCT04258137
Locations
🇫🇷

Centre hospitalier de la Côte Basque, Bayonne, France

🇫🇷

Institut Bergonie, Bordeaux, France

🇫🇷

Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France

and more 3 locations

Diagnostic Performances of Preoperative Echo-guided Uterine Biopsy in the Management of Suspect Uterine Sarcoma Tumors (BIOPSAR)

Not Applicable
Active, not recruiting
Conditions
Interventions
First Posted Date
2020-01-31
Last Posted Date
2024-11-19
Lead Sponsor
Institut Bergonié
Target Recruit Count
19
Registration Number
NCT04250766
Locations
🇫🇷

Institut Bergonié, Bordeaux, France

Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study

First Posted Date
2019-09-19
Last Posted Date
2023-02-22
Lead Sponsor
Institut Bergonié
Target Recruit Count
67
Registration Number
NCT04095208
Locations
🇫🇷

Institut Bergonié, Bordeaux, France

🇫🇷

Institut de Cancérologie de l'Ouest - Site René Gauducheau, Nantes, France

🇫🇷

Centre Léon Bérard, Lyon, France

and more 2 locations

MOLecular Characterization and Treatment of THYroid Carcinoma on Struma Ovarii

First Posted Date
2019-08-12
Last Posted Date
2019-08-12
Lead Sponsor
Institut Bergonié
Target Recruit Count
20
Registration Number
NCT04053114
Locations
🇫🇷

Institut Bergonié, Bordeaux, Aquitaine, France

Role of FDG-PET CT in the Management of Muscle Invasive Bladder Cancer

First Posted Date
2019-08-12
Last Posted Date
2019-08-12
Lead Sponsor
Institut Bergonié
Target Recruit Count
130
Registration Number
NCT04053101
Locations
🇫🇷

Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France

🇫🇷

Institut Bergonie, Bordeaux, France

A Retrospective Study to Determine the Incidence of NTRK Fusions. NTRK Study

First Posted Date
2019-07-08
Last Posted Date
2022-08-29
Lead Sponsor
Institut Bergonié
Target Recruit Count
3820
Registration Number
NCT04010240
Locations
🇫🇷

Institut Bergonié, Bordeaux, Aquitaine, France

© Copyright 2024. All Rights Reserved by MedPath